GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

19.96
Delayed Data
As of Jun 18
 -0.84 / -4.04%
Today’s Change
16.50
Today|||52-Week Range
21.26
+12.20%
Year-to-Date
Pharma Stock Roundup: AZN COVID-19 Antibody Cocktail Failure, GSK New Cancer Deal
Jun 18 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Antibody Cocktail Fails to Prevent COVID-19
Jun 16 / Zacks.com - Paid Partner Content
CureVac (CVAC) Plummets on Disappointing COVID-19 Vaccine Data
Jun 17 / Zacks.com - Paid Partner Content
Glaxo (GSK)/iTeos Therapeutics to Co-Develop Novel Cancer Drug
Jun 15 / Zacks.com - Paid Partner Content
CureVac shares drop 45% after disappointing Covid vaccine results
Jun 17 / CNN.com - Paid Partner Content
Why iTeos Therapeutics Stock Soared Today
Jun 14 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: SAGE Declines on Data, Regulatory Updates From VRTX, ITOS
Jun 16 / Zacks.com - Paid Partner Content
Is Pfizer Stock Undervalued?
Jun 13 / MotleyFool.com - Paid Partner Content
Regeneron (REGN) Announces Data on COVID-19 Antibody Cocktail
Jun 16 / Zacks.com - Paid Partner Content
Gilead (GILD) Gets FDA Nod for Label Expansion of Epclusa
Jun 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close20.80
Today’s open20.00
Day’s range19.69 - 20.60
Volume3,903,441
Average volume (3 months)288,260
Market cap$100.4B
Data as of 06/18/2021

Growth & Valuation

Earnings growth (last year)+23.68%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+1.55%
P/E ratio--
Price/Sales2.11
Price/Book4.99

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$43.7B
Annual profit (last year)$7.4B
Net profit margin16.86%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Middlesex, Greater London

Forecasts

Chart unavailable